Get the Stockscreener App
1.18
2.61%
0.03
After Hours:
1.19
0.01
+0.85%
Bioaffinity Technologies Inc stock is traded at $1.18, with a volume of 2.12M.
It is up +2.61% in the last 24 hours and down -13.87% over the past month.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
See More
Previous Close:
$1.15
Open:
$1.22
24h Volume:
2.12M
Relative Volume:
15.57
Market Cap:
$5.31M
Revenue:
$9.37M
Net Income/Loss:
$-8.45M
P/E Ratio:
-1.4568
EPS:
-0.81
Net Cash Flow:
$-7.27M
1W Performance:
+7.27%
1M Performance:
-13.87%
6M Performance:
-85.28%
1Y Performance:
-95.32%
1-Day Range:
$1.17
$1.39
1-Week Range:
$0.97
$1.39
52-Week Range:
$0.693
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
1.18 | 5.17M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
515.12 | 192.95B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
211.25 | 147.43B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
630.73 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
126.34 | 35.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
328.66 | 32.13B | 3.17B | 642.63M | 539.81M | 10.77 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer - Yahoo Finance
bioAffinity Highlights CyPath Lung Clinical Utility in Surveillance - TipRanks
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study - BioSpace
Setup Watch: What is bioAffinity Technologies Inc Equity Warrants valuation compared to sectorForecast Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Can bioAffinity Technologies Inc. Equity Warrant weather a recession2025 Historical Comparison & Safe Entry Momentum Tips - mfd.ru
How bioAffinity Technologies Inc. Equity Warrant stock performs in weak economyMarket Sentiment Summary & Risk Controlled Daily Trade Plans - mfd.ru
Is bioAffinity Technologies Inc.’s growth already priced in - mfd.ru
Growth Recap: Will bioAffinity Technologies Inc outperform tech stocksTrade Ideas & Technical Buy Zone Confirmations - baoquankhu1.vn
Will bioAffinity Technologies Inc. benefit from AI trends2025 Investor Takeaways & Low Volatility Stock Suggestions - mfd.ru
Momentum Shift: What is the implied volatility of bioAffinity Technologies IncEntry Point & Intraday High Probability Alerts - baoquankhu1.vn
bioAffinity Technologies Updates Investor Presentation Materials Online - The Globe and Mail
Can bioAffinity Technologies Inc. stock continue upward trendTrade Analysis Report & Accurate Buy Signal Notifications - mfd.ru
bioAffinity Technologies expands medical advisory board with lung experts By Investing.com - Investing.com South Africa
bioAffinity Adds Leading Lung Cancer Experts to Advisory Board - TipRanks
bioAffinity Technologies Appoints New Advisory Board Members - TradingView
bioAffinity Technologies Appoints Three Physicians to Medical and Scientific Advisory Board - citybiz
bioAffinity Technologies expands medical advisory board with lung experts - Investing.com
BioAffinity Technologies, Inc. Announces Medical and Scientific Advisory Board Appointments - marketscreener.com
bioAffinity Sets 2026 Annual Meeting, Revives Prior Proposals - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
AI Stocks: Is bioAffinity Technologies Inc affected by consumer sentimentWeekly Risk Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Bank Watch: Will bioAffinity Technologies Inc benefit from sector rotationJuly 2025 Fed Impact & Fast Entry Momentum Alerts - baoquankhu1.vn
Gainers Report: Can bioAffinity Technologies Inc Equity Warrant outperform under higher oil prices2025 Winners & Losers & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Aug Patterns: Will bioAffinity Technologies Inc outperform tech stocksJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Market Recap: Can bioAffinity Technologies Inc Equity Warrant weather a recessionWeekly Trade Analysis & High Accuracy Swing Trade Signals - baoquankhu1.vn
Is bioAffinity Technologies Inc. stock a value trap2025 Breakouts & Breakdowns & Weekly Return Optimization Alerts - mfd.ru
Aug Fed Impact: Is FingerMotion Inc in a long term uptrendWeekly Gains Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Patterns Watch: Is bioAffinity Technologies Incs growth already priced in - baoquankhu1.vn
Aug Analyst Calls: What is bioAffinity Technologies Inc Equity Warrants valuation compared to sectorEarnings Miss & AI Optimized Trade Strategies - baoquankhu1.vn
Stock Recap: What are the future prospects of bioAffinity Technologies Inc Equity WarrantJuly 2025 Sentiment & Consistent Income Trade Ideas - baoquankhu1.vn
Earnings Recap: What are the future prospects of bioAffinity Technologies Inc Equity WarrantEarnings Overview Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Market Trends: Is bioAffinity Technologies Incs growth already priced inShare Buyback & Weekly Top Gainers Alerts - baoquankhu1.vn
bioAffinity Adjourns Special Stockholder Meeting for Lack Quorum - MSN
Why bioAffinity Technologies Inc. Equity Warrant stock appeals to dividend seekersPortfolio Value Report & Fast Entry Momentum Alerts - Улправда
Will bioAffinity Technologies Inc. stock pay special dividendsJuly 2025 Sector Moves & Low Risk High Win Rate Picks - Улправда
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - FinancialContent
Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growth2025 Key Lessons & Weekly Momentum Picks - Улправда
Is bioAffinity Technologies Inc. stock trading at a premium valuation2025 Dividend Review & Advanced Technical Analysis Signals - ulpravda.ru
Will bioAffinity Technologies Inc. stock outperform tech sector in 2025Quarterly Growth Report & Free Fast Entry Momentum Trade Alerts - Улправда
Is bioAffinity Technologies Inc. Equity Warrant stock cheap compared to fundamentalsJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - Улправда
Is bioAffinity Technologies Inc. stock ready for breakoutJuly 2025 Weekly Recap & AI Driven Price Predictions - ulpravda.ru
Can bioAffinity Technologies Inc. stock maintain growth trajectoryWeekly Market Summary & Detailed Earnings Play Strategies - Улправда
Is bioAffinity Technologies Inc. Equity Warrant stock a buy for dividend growthMarket Volume Summary & AI Powered Market Trend Analysis - ulpravda.ru
Will bioAffinity Technologies Inc. stock attract ESG investorsWeekly Trade Summary & Stock Timing and Entry Methods - Улправда
Will bioAffinity Technologies Inc. Equity Warrant stock attract ESG investors2025 Fundamental Recap & Daily Chart Pattern Signals - Улправда
How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peersFundamental Stock Analysis & Small Entry Cost Stocks - Улправда
bioAffinity Labs Maintain CAP Accreditation, Supporting CyPath Lung - TipRanks
bioAffinity Technologies Maintains CAP Accreditation - TradingView — Track All Markets
bioAffinity Technologies (BIAF) lab unit keeps College of American Pathologists accreditation - Stock Titan
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation - Business Wire
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):